OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Jun 8, 2007
Insider Transaction Report
Form 4
VENTURETEC INC
10% Owner
Transactions
- Sale
Convertible Promissory Note
2007-06-06$18.00/sh−4,000,000$72,000,000→ 0 totalExercise: $18.00From: 2007-02-09Exp: 2009-04-30→ Common Stock (222,222 underlying) - Purchase
Common Stock
2007-06-06$11.38/sh+263,620$2,999,996→ 3,863,620 total
Footnotes (2)
- [F1]Shares acquired in a private placement under Regulation S of the Securities Act of 1933. The securities have not been registered under the United States Securities Act of 1933, as amended, or any state securities laws. Pursuant to the terms of the placement, the holders are provided demand registration rights for the purchased shares, but only after such time as the Issuer becomes eligible to effect such registration pursuant to a registration statement on Form S-3 or another "short-form" registration statement
- [F2]Represents the transfer and conveyence of the Convertible Promissory Note, dated October 30, 2006 of the Issuer in the original principal amount of $4,000,000 issued to the Reporting Person in a private transaction. The Note was assigned to Peter Friedli who serves as the Chairman of the Board of Directors of the Issuer and the President of the Reporting Person.